Topical MW-III

MW-III · Skingenix, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Topical MW-III, covering 2026-03-16 to 2026-03-16. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns [Phase 2]